4-[(3-chloro-4-fluorophenyl)amino]-6-[4-[N-(2-carboxyethyl)-N-methylamino]piperidin-1-yl]pyrimido[5,4-d]pyrimidine

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: 4-[(3-chloro-4-fluorophenyl)amino]-6-[4-[N-(2-carboxyethyl)-N-methylamino]piperidin-1-yl]pyrimido[5,4-d]pyrimidine
• 英文别名: 3-[[1-[4-(3-Chloro-4-fluoroanilino)pyrimido[5,4-d]pyrimidin-6-yl]piperidin-4-yl]-methylamino]propanoic acid
• 化学式: C₂₁H₂₃ClFN₇O₂
• 分子量: 459.911
• InChiKey: PZPYVXNWAMAWOS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.8
• 重原子数：
  32
• 可旋转键数：
  7
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.38
• 拓扑面积：
  107
• 氢给体数：
  2
• 氢受体数：
  10

文献信息

• Bicyclic heterocycles, pharmaceutical compositions containing them, their use, and processes for preparing them
  申请人：——

  公开号：US20020082420A1

  公开（公告）日：2002-06-27

  A compound of formula (I) 1 wherein R a , R b , X, and Y are as defined herein, or a tautomer, stereoisomer, or salt thereof, particularly a physiologically acceptable salt thereof. In addition, pharmaceutical compositions comprising an effective amount of a compound of formula (I), methods for the treatment or prophylaxis of benign or malignant tumors, diseases of the airways and lungs, polyps, diseases of the gastrointestinal tract, bile duct, gall bladder, kidneys, and skin, and methods for making compounds of formula (I) are disclosed.

  式（I）的化合物，其中Ra、Rb、X和Y如本文所定义，或其互变异构体、立体异构体或盐，特别是其生理上可接受的盐。此外，还披露了包含式（I）化合物有效量的药物组合物，用于治疗或预防良性或恶性肿瘤、呼吸道和肺部疾病、息肉、胃肠道、胆道、胆囊、肾脏和皮肤疾病的方法，以及制备式（I）化合物的方法。